Article

Artificial intelligence (AI) and machine learning (ML) have the potential to revolutionize drug discovery, but their impact will be limited once we are able to generate more high-quality data. In a recent op-ed, Neil and Jason argue that AI/ML without quality data creates smoke and mirrors.

Click Op-ed in Drug Discovery Online To Read More